FY2025 · ended Dec 31, 2025 · Revenue $1.45B · Filed Mar 11, 2026
Guardian Pharmacy Services, Inc. (GRDN) files with the SEC under industry code 5912, Retail-Drug Stores and Proprietary Stores. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.4 billion and net income of $49.2 million. Free cash flow was $86.8 million. As of Jun 30, 2026 it held $89.8 million in cash and investments and $35.2 million in total debt.
Revenue (TTM)
$1.46B
Net income (TTM)
$65.91M
Operating cash flow (TTM)
$98.86M
Free cash flow (TTM)
$94.36M
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
$54.57M
as of Jun 30, 2026
Operating margin
5.8%
FY 2026
Company profile
- Industry
- Retail-Drug Stores and Proprietary Stores (SIC 5912)
- Listed as
- GRDN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- GA
- Headquarters
- Atlanta, GA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1802255
- Former names
- Guardian Pharmacy Services, Inc. (until Sep 28, 2026); Guardian Pharmacy, LLC (until Jul 23, 2021)
Other Retail-Drug Stores and Proprietary Stores companies
- CVS HEALTH Corp CVS
- 111, Inc. YI
- Petmed Express Inc PETS
- Ridgetech Inc. RDGT
- TREES Corp (Colorado) CANN
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
|---|---|
| Revenue | $1.4B |
| Operating income | $72.7M |
| Net income | $49.2M |
| Operating cash flow | $100.3M |
| Free cash flow | $86.8M |
| Total assets | $412.7M |
| Total liabilities | $194.7M |
| Stockholders' equity | $217.9M |
| Cash and investments | $65.6M |
| Total debt | $44.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 10, 2026 | Sep 10, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 22, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
May 28, 2026 | May 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 7, 2026 | May 5, 2026 |
All 223 Guardian Pharmacy Services, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.